Vivek M. Rangnekar
- Cancer Research top 2%
- NF-κB Signaling Pathways 7
- Molecular Biology top 1%
- Cell death mechanisms and regulation 44
- RNA Interference and Gene Delivery 11
- PI3K/AKT/mTOR signaling in cancer 9
- Renal and related cancers 8
- Cell Biology top 1%
- Hippo pathway signaling and YAP/TAZ 11
- Endoplasmic Reticulum Stress and Disease 8
- Oncology top 2%
- Cancer-related Molecular Pathways 19
- Pharmacology top 1%
- Co-authors
- Stephen F. SellsKrishna Murthi VasudevanSushma GurumurthyRavshan BurikhanovShirley QiuAnindya GoswamiNadia El-GuendyXueqin Song
- Partner nations
- United StatesIndiaPoland
In The Last Decade
Vivek M. Rangnekar
117 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 960
- Molecular Biology 4.1k
- Cell Biology 879
- Oncology 1.3k
- Pharmacology 600
Countries citing papers authored by Vivek M. Rangnekar
This map shows the geographic impact of Vivek M. Rangnekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek M. Rangnekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek M. Rangnekar more than expected).
Fields of papers citing papers by Vivek M. Rangnekar
This network shows the impact of papers produced by Vivek M. Rangnekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek M. Rangnekar. The network helps show where Vivek M. Rangnekar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vivek M. Rangnekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 16 | |
| 5 | 2021 | 10 | |
| 6 | 2018 | 6 | |
| 7 | 2017 | 21 | |
| 8 | 2017 | 20 | |
| 9 | 2012 | 40 | |
| 10 | 2009 | 55 | |
| 11 | 2009 | 8 | |
| 12 | 2008 | 27 | |
| 13 | 2007 | 45 | |
| 14 | 2007 | 113 | |
| 15 | 2007 | 67 | |
| 16 | 2003 | 49 | |
| 17 | 2002 | 1 | |
| 18 | 2001 | 37 | |
| 19 | 1997 | 159 | |
| 20 | 1996 | 18 |
About Vivek M. Rangnekar
Vivek M. Rangnekar is a scholar working on Cell Biology, Molecular Biology and Cancer Research, having authored 119 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (44 papers), Cancer-related Molecular Pathways (19 papers), RNA Interference and Gene Delivery (11 papers), Hippo pathway signaling and YAP/TAZ (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Endoplasmic Reticulum Stress and Disease (8 papers), Renal and related cancers (8 papers) and NF-κB Signaling Pathways (7 papers). The work is most often cited by research in Cancer Research (960 citations), Molecular Biology (4.1k citations) and Cell Biology (879 citations). Vivek M. Rangnekar has collaborated with scholars based in United States, India and Poland. Frequent co-authors include Stephen F. Sells, Krishna Murthi Vasudevan, Sushma Gurumurthy, Ravshan Burikhanov, Shirley Qiu, Anindya Goswami, Nadia El-Guendy, Xueqin Song, Tsui‐Ting Ching and Ching-Shih Chen. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.